Medline (NASDAQ:MDLN) Receives $50.62 Average Target Price from Analysts

Shares of Medline (NASDAQ:MDLN) have been given a consensus rating of “Moderate Buy” by the twenty-nine brokerages that are presently covering the stock, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold recommendation, twenty-one have given a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $50.6154.

A number of brokerages have weighed in on MDLN. BNP Paribas Exane began coverage on Medline in a research note on Monday, January 12th. They set a “neutral” rating and a $38.00 price objective for the company. Zacks Research upgraded Medline to a “hold” rating in a research note on Tuesday, January 13th. Wolfe Research initiated coverage on shares of Medline in a research report on Monday, January 12th. They set an “outperform” rating and a $47.00 price target for the company. JPMorgan Chase & Co. lifted their price target on shares of Medline from $50.00 to $53.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 10th. Finally, Jefferies Financial Group began coverage on shares of Medline in a research note on Monday, January 12th. They set a “buy” rating and a $50.00 price objective on the stock.

Institutional Trading of Medline

Several institutional investors and hedge funds have recently bought and sold shares of the company. Sound Income Strategies LLC acquired a new position in Medline during the 4th quarter valued at approximately $25,000. Entrust Financial LLC acquired a new stake in Medline in the fourth quarter worth $26,000. NBC Securities Inc. bought a new stake in Medline in the fourth quarter valued at $28,000. Global Retirement Partners LLC acquired a new position in shares of Medline during the fourth quarter valued at $31,000. Finally, North Star Investment Management Corp. acquired a new position in shares of Medline during the fourth quarter valued at $36,000.

Medline Trading Down 1.1%

Shares of MDLN stock opened at $44.00 on Friday. The business has a fifty day moving average price of $44.74. Medline has a 12 month low of $34.89 and a 12 month high of $50.88.

Medline (NASDAQ:MDLN) last announced its earnings results on Wednesday, February 25th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.25). The firm had revenue of $7.79 billion during the quarter, compared to analyst estimates of $7.52 billion. The business’s revenue for the quarter was up 14.8% compared to the same quarter last year.

About Medline

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.